554
Views
0
CrossRef citations to date
0
Altmetric
Brief Report

Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis)

, , , , , , ORCID Icon, , , ORCID Icon, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Article: 2350760 | Received 23 Apr 2024, Accepted 29 Apr 2024, Published online: 07 May 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.